{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:11:32Z","timestamp":1778847092951,"version":"3.51.4"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006021","name":"General Directorate of Armaments","doi-asserted-by":"publisher","award":["NBC2-B-2120"],"award-info":[{"award-number":["NBC2-B-2120"]}],"id":[{"id":"10.13039\/501100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR 10-IAHU"],"award-info":[{"award-number":["ANR 10-IAHU"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijpddr.2026.100633","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:46:18Z","timestamp":1768610778000},"page":"100633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence of antimalarial drug resistance molecular markers in Makenene, central Cameroon"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0661-2334","authenticated-orcid":false,"given":"Nelly Armanda","family":"Kala-Chouakeu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Djoufounna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timol\u00e9on","family":"Tchuinkam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oc\u00e9ane","family":"Delandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Almeras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Bamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Antonio-Nkondjio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marylin","family":"Madamet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-3803","authenticated-orcid":false,"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2026.100633_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1475-2875-13-204","article-title":"Designing and implementing interventions to change clinician\u2019practice in the management of uncomplicated malaria: lessons from Cameroon","volume":"13","author":"Achonduh","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib2","first-page":"149","article-title":"Sensibilit\u00e9 in vivo et in vitro de Plasmodium falciparum \u00e0 la chloroquine et \u00e0 l\u2019amodiaquine \u00e0 Bangangte (ouest-Cameroun)","volume":"88","author":"Agnamey","year":"1995","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"10.1016\/j.ijpddr.2026.100633_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11861","article-title":"Allelic frequencies of mutants of the Plasmodium falciparum, quinoline and folate metabolizing genes in the west region of Cameroon","volume":"8","author":"Ali","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ijpddr.2026.100633_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305064","article-title":"Day 3 parasitemia and Plasmodium falciparum kelch 13 mutations among complicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda","volume":"19","author":"Angwe","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2026.100633_bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s13071-019-3753-8","article-title":"Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination","volume":"12","author":"Antonio-Nkondjio","year":"2019","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2026.100633_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/biomedicines4010005","article-title":"In vivo efficacy of artesunate\/sulphadoxine-pyrimethamine versus artesunate\/amodiaquine in the treatment of uncomplicated P. falciparum malaria in children around the slope of Mount Cameroon: a randomized controlled trial","volume":"4","author":"Apinjoh","year":"2016","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijpddr.2026.100633_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40249-017-0350-y","article-title":"Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of Mount Cameroon: crosssectional study","volume":"6","author":"Apinjoh","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.ijpddr.2026.100633_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2026.100633_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2026.100633_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.03647-14","article-title":"In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina-Faso","volume":"59","author":"Baraka","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib11","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1002\/j.1460-2075.1992.tb05378.x","article-title":"Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum","volume":"11","author":"Barnes","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4269\/ajtmh.2002.67.383","article-title":"Molecular epidemiology of malaria in Cameroon. XII. In vitro drug assays and molecular surveillance of chloroquine and proguanil resistance","volume":"67","author":"Basco","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4269\/ajtmh.2003.69.174","article-title":"Molecular epidemiology of malaria in Cameroon. XVI. Longitudinal surveillance of in vitro pyrimethamine resistance in Plasmodium falciparum","volume":"69","author":"Basco","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.2006.75.388","article-title":"Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change","volume":"75","author":"Basco","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4269\/ajtmh.2007.76.20","article-title":"Molecular epidemiology of malaria in Cameroon. XXIV. Trends of in vitro antimalarial drug responses in Yaound\u00e9, Cameroon","volume":"76","author":"Basco","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib16","series-title":"Rapport Annuel D\u2019Activit\u00e9 2024. Ann\u00e9e D\u2019Exercice 2023","year":"2024"},{"key":"10.1016\/j.ijpddr.2026.100633_bib17","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/jac\/dkv160","article-title":"Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine\/pyrimethamine in pregnant women in Yaound\u00e9, Cameroon: emergence of highly resistant pfdhfr\/pfdhps alleles","volume":"70","author":"Chauvin","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jac\/dkac432","article-title":"Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation","volume":"78","author":"Cohen","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib19","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.3390\/jcm13226828","article-title":"Dihydro-artemisinin-piperaquine combination in the treatment of uncomplicated Plasmodium falciparum malaria: update on clinical failures in Africa and tools for surveillance","volume":"13","author":"Delandre","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijpddr.2026.100633_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02731-18","article-title":"Global spread of mutant PfCRT and its pleitrophic impact on Plasmodium falciparum multidrug resistance and fitness","volume":"10","author":"Dhingra","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2026.100633_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4269\/ajtmh.16-0889","article-title":"Molecular epidemiology of malaria in Cameroon and C\u00f4te d'Ivoire. XXXI. Kelch 13 propeller sequences in Plasmodium falciparum isolates before and after implementation of artemisinin-based combination therapy","volume":"97","author":"Djaman","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib22","first-page":"231","article-title":"A five-year malaria prevalence\/frequency in Makenene in a forest-savannah transition ecozone of Central Cameroon: the results of a retrospective study","volume":"9","author":"Djoufounna","year":"2024","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12936-022-04253-z","article-title":"Population knowledge, attitudes and practices towards malaria prevention in the locality of Makenene, centre-cameroon","volume":"21","author":"Djoufounna","year":"2022","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib24","article-title":"High prevalence of asymptomatic Plasmodium falciparum malaria in Makenene, a locality in the forest-savannah transition zone, centre region of Cameroon","volume":"2","author":"Djoufounna","year":"2022","journal-title":"Curr. Res. Parasitol. Vector Borne Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib25","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/AAC.50.5.1893-1895.2006","article-title":"Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic","volume":"50","author":"Dokomajilar","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2026.100633_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221895","article-title":"K-13 propeller gene polymorphisms isolated between 2014 and 2017 from Cameroonian Plasmodium falciparum malaria patients","volume":"14","author":"Eboumbou Moukoko","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2026.100633_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/pathogens12060844","article-title":"Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnancy: low coverage and high prevalence of Plasmodium falciparum dhfr-dhps quintuple mutants as major challenges in douala, an urban setting in Cameroon","volume":"12","author":"Eboumbou Moukoko","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ijpddr.2026.100633_bib29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijpddr.2026.100633_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12936-020-03281-x","article-title":"Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates","volume":"19","author":"Foguim","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actatropica.2019.05.020","article-title":"Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5)","volume":"196","author":"Gendrot","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2026.100633_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1475-2875-12-35","article-title":"Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travelers returning from west and Central Africa, 2000-2011","volume":"12","author":"Gharbi","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12936-020-03263-z","article-title":"Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni county referral hospital, Kwale county, Kenya","volume":"19","author":"Gikunju","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib34","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1016\/S2666-5247(23)00211-2","article-title":"Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine-pyrimethamine in central Africa: a cross-sectional study","volume":"4","author":"Gu\u00e9mas","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijpddr.2026.100633_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the greater mekong subregion: a molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib36","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","article-title":"Evidence of artemisinin partial resistance in north-western Tanzania: clinical and drug resistance markers study","volume":"24","author":"Ishengoma","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib37","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2004.09.012","article-title":"Evidence for a central role of PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents","volume":"15","author":"Johnson","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijpddr.2026.100633_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12936-016-1387-2","article-title":"Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania","volume":"15","author":"Kavishe","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00884-24","article-title":"Novel Plasmodium falciparum Kelch13 pomymorphisms in Cameroon with structural and physicochemical impact","volume":"69","author":"Kojom Foko","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/338566","article-title":"Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria","volume":"185","author":"Kublin","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijid.2021.04.081","article-title":"Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon","volume":"107","author":"L'Espiscopia","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib42","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1128\/AAC.01394-10","article-title":"K540N mutation in Plasmodium falciparum dihydropteroate synthase confers a lower level of sulfa drug resistance than does a K540E mutation","volume":"55","author":"Lumb","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib43","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/jac\/dkab281","article-title":"Efficacy of dihydroartemisinin\/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaound\u00e9, Cameroon","volume":"76","author":"Mairet-Khedim","year":"2021","journal-title":"J. Antimicro. Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib44","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1186\/s12879-024-09868-y","volume":"24","author":"Martinez-Vega","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12936-023-04485-7","article-title":"Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine-pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon region","volume":"22","author":"Mbacham","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2875-9-34","article-title":"Efficacy of amodiaquine, sulfadoxine-pyrimethamine and their combination for the treatement of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy","volume":"9","author":"Mbacham","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/jac\/dkt388","article-title":"Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum","volume":"69","author":"Mbenda","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib48","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A world-wide map of Plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"M\u00e9nard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2026.100633_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1475-2875-11-113","article-title":"Molecular monitoring of Plasmodium falciparum drug susceptibility in Yaound\u00e9, Cameroon: implication for the future","volume":"11","author":"Menard","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib50","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12936-016-1622-x","article-title":"Insight into k13-propeler gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates","volume":"15","author":"Menard","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib51","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/trstmh\/traf040","article-title":"Investigating PfK13 mutations in Plasmodium falciparum natural populations from two malaria-endemic areas of Cameroon","volume":"119","author":"Milong Melong","year":"2025","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Generic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijpddr.2026.100633_bib53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/infdis\/jit415","article-title":"Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite","volume":"209","author":"Mita","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/20477724.2022.2056674","article-title":"Current status of 4-aminoquinoline resistance markers 18 years after cessation of chloroquine use for the treatment of uncomplicated falciparum malaria in the littoral coastline region of Cameroon","volume":"116","author":"Moyeh","year":"2022","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ijpddr.2026.100633_bib55","article-title":"Effects of drug policy changes on evolution of molecular markers of Plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the south west region of Cameroon","volume":"2018","author":"Moyeh","year":"2018","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.ijpddr.2026.100633_bib56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0035-9203(92)90226-3","article-title":"Increase of chloroquine resistance in vivo of Plasmodium falciparum over two years in Edea, south Cameroon","volume":"86","author":"Mulder","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib57","first-page":"505","article-title":"Mapping \u201cpartially resistant\u201d","volume":"29","author":"Naidoo","year":"2013","journal-title":"\u201cfully resistant\u201d, and \u201csuper resistant\u201d malaria. Trends Parasitol"},{"key":"10.1016\/j.ijpddr.2026.100633_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2022.102657","article-title":"Anti-folate quintuple mutations in Plasmodium falciparum asymptomatic infections in Yaound\u00e9, Cameroon","volume":"92","author":"Nana","year":"2023","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2026.100633_bib59","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1128\/AAC.00920-16","article-title":"Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandanschoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity","volume":"60","author":"Nankabirwa","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12936-017-1783-2","article-title":"Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon","volume":"16","author":"Ndam","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12879-022-07101-2","article-title":"Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaound\u00e9, Cameroon: a randomized trial","volume":"22","author":"Niba","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijid.2023.03.050","article-title":"Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde","volume":"132","author":"Niba","year":"2023","journal-title":"Cameroon. Int. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12936-020-03543-8","article-title":"Drug resistance markers within an evolving efficacy of anti-malaria drugs in Cameroon: a systematic review and meta-analysis (1998-2020)","volume":"20","author":"Niba","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12936-014-0521-2","article-title":"Randomized non-inferiority and safety trial of dihydroartemisinin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children","volume":"14","author":"Nji","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146339","article-title":"Xeno-monitoring of molecular drivers of artemisinin and partner drug resistance in P. falciparum populations in malaria vectors across Cameroon","volume":"821","author":"Nkemngo","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.ijpddr.2026.100633_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00588-23","article-title":"Geographical emergence of sulfadoxine-pyrimethamine drug resistance-associated P. falciparum and P. malariae alleles in co-existing Anopheles mosquito and asymptomatic human populations across Cameroon","volume":"67","author":"Nkemngo","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib67","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in Western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2026.100633_bib68","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidine synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ijpddr.2026.100633_bib69","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","article-title":"Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study","volume":"379","author":"Phyo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2026.100633_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2875-8-89","article-title":"A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria","volume":"8","author":"Picot","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib71","first-page":"59","article-title":"Implication des pompes membranaires de Plasmodium falciparum dans le transport et la r\u00e9sistance aux antipaludiques","volume":"519","author":"Pradines","year":"2020","journal-title":"Rev. Fr. Lab."},{"key":"10.1016\/j.ijpddr.2026.100633_bib72","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","article-title":"The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand","volume":"43","author":"Price","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib75","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35002615","article-title":"Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum","volume":"403","author":"Reed","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2026.100633_bib76","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.1365-3156.2000.00613.x","article-title":"Chimior\u00e9sistance de P. falciparum en milieu urbain \u00e0 Yaound\u00e9, Cameroun. Part I: surveillance in vitro et in vivo de la r\u00e9sistance de Plasmodium falciparum \u00e0 la chloroquine entre 1994 et 1999 \u00e0 Yaound\u00e9, Cameroun","volume":"9","author":"Ringwald","year":"2000","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2026.100633_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00188-22","article-title":"Genetic diversity of Plasmodium falciparum and distribution of antimalarial drug resistance mutations in symptomatic and asymptomatic infections","volume":"66","author":"Sarah-Matio","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1475-2875-8-176","article-title":"Treatment of malaria from monotherapy to artemisinin-based combination therapy by healthprofessionals in urban health facilities in Yaound\u00e9, central province, Cameroon","volume":"8","author":"Sayang","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib79","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1471-4922(01)02085-2","article-title":"Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?","volume":"17","author":"Sibley","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100633_bib80","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","article-title":"Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum","volume":"57","author":"Sidhu","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100633_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6688380","article-title":"Status of multidrug resistance-1 gene of Plasmodium falciparum in four malaria epidemiological strata, two decades after the abolition of chloroquine as first-line treatment for uncomplicated malaria in Cameroon","volume":"2023","author":"Sofeu-Feugaing","year":"2023","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.ijpddr.2026.100633_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151565","article-title":"Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of Pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso","volume":"11","author":"Sondo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2026.100633_bib83","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)","volume":"191","author":"Sosowath","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib84","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","article-title":"High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine","volume":"225","author":"Straimer","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib85","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1186\/s12889-024-19887-8","article-title":"Effectiveness of malaria chemoprevention in the first two years of live in Cameroon and C\u00f4te d'ivoire compared to standard of care: study protocol for a population-based prospective cohort impact evaluation study","volume":"24","author":"Stresman","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijpddr.2026.100633_bib86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.actatropica.2007.04.008","article-title":"Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatement and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children","volume":"103","author":"Tahar","year":"2007","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2026.100633_bib87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4269\/ajtmh.2007.77.221","article-title":"Molecular epidemiology of malaria in Cameroon. XXVI. Twelve-year in vitro and molecular surveillance of pyrimethamine resistance and experimental studies to modulate pyrimethamine resistance","volume":"77","author":"Tahar","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib88","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4269\/ajtmh.2006.75.396","article-title":"Molecular epidemiology of malaria in Cameroon. XXII. Geographic mapping and distribution of Plasmodium falciparum dihydrofolate reductase (dhfr) mutant alleles","volume":"75","author":"Tahar","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib89","article-title":"Artemether-lumefantrine and dihydroartemisinin-piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda","volume":"4","author":"Taylor","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256343","article-title":"Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes","volume":"16","author":"Tuedom","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2026.100633_bib91","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy stidy","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalence PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2026.100633_bib93","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2026.100633_bib94","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2958.1997.2821646.x","article-title":"Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthase and additional factor associated with folate utilization","volume":"23","author":"Wang","year":"1997","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100633_bib95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12936-020-3140-0","article-title":"Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018","volume":"19","author":"Wang","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib96","article-title":"Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Central Africa between 2016 and 2021: wide geographic spread of highly mutated Pfdhfr and Pfdhps alleles","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol. Spectum."},{"key":"10.1016\/j.ijpddr.2026.100633_bib97","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature00813","article-title":"Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum","volume":"418","author":"Wootton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2026.100633_bib102","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/AAC.03494-14","article-title":"Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine and dihydroartemisinin","volume":"58","author":"Wurtz","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100633_bib103","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/1475-2875-10-336","article-title":"Vivax malaria in Mauritania includes infection of Duffy-negative individual","volume":"10","author":"Wurtz","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2026.100633_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1239274","article-title":"Molecular markers associated with drug resistance in Plasmodium falciparum parasites in central Africa between 2016 and 2021","volume":"11","author":"Xu","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ijpddr.2026.100633_bib105","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jiv551","article-title":"Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial","volume":"213","author":"Yeka","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100633_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-018-0259-3","article-title":"Monitoring the efficacy and safety of artemisinin-based combination therapies: a review and network meta-analysis of antimalarial therapeutic efficacy trials in Cameroon","volume":"19","author":"Youdom","year":"2019","journal-title":"Drugs R&D"},{"key":"10.1016\/j.ijpddr.2026.100633_bib107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0166-6851(89)90173-4","article-title":"Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis of pyrimethamine resistance in Plasmodium falciparum","volume":"36","author":"Zolg","year":"1989","journal-title":"Mol. Biochem. Parasitol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320726000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320726000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:40:49Z","timestamp":1778845249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320726000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":101,"alternative-id":["S2211320726000035"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2026.100633","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of antimalarial drug resistance molecular markers in Makenene, central Cameroon","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2026.100633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100633"}}